Clinical Trial Update: Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the combination of 611 with topical corticosteroid for moderate-to-severe atopic dermatitis; the trial is active and not currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 611

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Dermatitis, Atopic, Eczema, Atopic | Phase 3 | Status: ACTIVE_NOT_RECRUITING